PARIS (Reuters) – Sanofi will decide shortly whether to seek regulatory approval for its dengue vaccine Dengvaxia in the United States and remains committed to the medicine despite a health scare in the Philippines, a senior executive said on Wednesday. David Loew, head of Sanofi Pasteur, the …
Google Alert – philippine US